" Since we’re still working on the trials, we’re enrolling individuals 55 or older. We’re not looking at unusual genetic predispositions for early onset- we’re really looking at late-onset disease. This doesn’t mean it won’t be applicable for earlier forms of the disease- we’re just not there yet as we are planning for another test trial first. Eventually, we will roll out the testing so that people who are in their 30s or 40s can receive retinal screening when going to an optometrist on a regular basis. That would be the time to get a nice baseline and start tracking someone and following tiny microscopic changes in their retina. I agree that it can be very discouraging to know that you’re high risk when there isn’t a therapeutic available but unfortunately we’re at a point where we have to do something to identify high risk persons early or we won’t be able to develop an effective therapeutic. "
We are glad you have chosen to leave a comment. Please keep in mind that comments are moderated according to our comment policy.